Page last updated: 2024-08-24

telmisartan and Angiitis

telmisartan has been researched along with Angiitis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Finger, S; Garlapati, V; Karbach, SH; Knopp, T; Knorr, M; Kossmann, S; Lagrange, J; Molitor, M; Münzel, T; Nguyen, TS; Rudi, WS; Ruf, W; Schüler, R; Wenzel, P; Wild, J1
Bae, SJ; Chang, J; Cho, DH; Cho, KW; Jo, I; Park, JH; Song, KH1
Cianchetti, S; Colognato, R; Del Fiorentino, A; Di Stefano, R; Franzoni, F; Pedrinelli, R1
Asano, A; Chujo, D; Kobayashi, J; Mabuchi, H; Muramoto, H; Ohnishi, A; Sakai, S; Shintaku-Kubota, M; Yagi, K; Yamagishi, M1

Trials

1 trial(s) available for telmisartan and Angiitis

ArticleYear
Telmisartan treatment decreases visceral fat accumulation and improves serum levels of adiponectin and vascular inflammation markers in Japanese hypertensive patients.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2007, Volume: 30, Issue:12

    Topics: Adiponectin; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; C-Reactive Protein; Cholesterol, HDL; Female; Humans; Hypertension; Insulin Resistance; Interleukin-6; Intra-Abdominal Fat; Japan; Male; Middle Aged; PPAR gamma; Regional Blood Flow; Telmisartan; Vasculitis

2007

Other Studies

3 other study(ies) available for telmisartan and Angiitis

ArticleYear
Nox2+ myeloid cells drive vascular inflammation and endothelial dysfunction in heart failure after myocardial infarction via angiotensin II receptor type 1.
    Cardiovascular research, 2021, 01-01, Volume: 117, Issue:1

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Genetically Modified; Disease Models, Animal; Endothelial Cells; Heart Failure; Leukocyte Rolling; Macrophages; Male; Mice, Inbred C57BL; Monocytes; Muramidase; Myeloid Cells; Myocardial Infarction; NADPH Oxidase 2; Oxidative Stress; Receptor, Angiotensin, Type 1; Signal Transduction; Telmisartan; Vasculitis

2021
Telmisartan mitigates hyperglycemia-induced vascular inflammation by increasing GSK3β-Ser
    Biochemical and biophysical research communications, 2017, 09-30, Volume: 491, Issue:4

    Topics: Animals; Aorta; Benzimidazoles; Benzoates; Cattle; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Glycogen Synthase Kinase 3 beta; Hyperglycemia; Inflammation; Male; Mice; Mice, Inbred C57BL; Phosphorylation; Phosphoserine; Structure-Activity Relationship; Telmisartan; Vasculitis

2017
Anti-inflammatory and anti-oxidant properties of telmisartan in cultured human umbilical vein endothelial cells.
    Atherosclerosis, 2008, Volume: 198, Issue:1

    Topics: Angiotensin II Type 1 Receptor Blockers; Anti-Inflammatory Agents; Antioxidants; Benzimidazoles; Benzoates; Cells, Cultured; Endothelial Cells; Humans; Hydrogen Peroxide; Intercellular Adhesion Molecule-1; Oxidants; Oxidative Stress; PPAR gamma; Receptor, Angiotensin, Type 1; Telmisartan; Tumor Necrosis Factor-alpha; Umbilical Veins; Vascular Cell Adhesion Molecule-1; Vasculitis

2008